TECH vs. MTD, WAT, ILMN, CRL, BIO, BRKR, PACB, HBIO, TMO, and A
Should you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.
Bio-Techne vs. Its Competitors
Mettler-Toledo International (NYSE:MTD) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.
95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by company insiders. Comparatively, 3.9% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Mettler-Toledo International has a net margin of 22.17% compared to Bio-Techne's net margin of 10.89%. Bio-Techne's return on equity of 13.17% beat Mettler-Toledo International's return on equity.
Mettler-Toledo International has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.
In the previous week, Mettler-Toledo International had 9 more articles in the media than Bio-Techne. MarketBeat recorded 16 mentions for Mettler-Toledo International and 7 mentions for Bio-Techne. Mettler-Toledo International's average media sentiment score of 1.39 beat Bio-Techne's score of 1.32 indicating that Mettler-Toledo International is being referred to more favorably in the media.
Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.
Mettler-Toledo International currently has a consensus target price of $1,300.36, suggesting a potential upside of 7.81%. Bio-Techne has a consensus target price of $72.00, suggesting a potential upside of 35.39%. Given Bio-Techne's stronger consensus rating and higher possible upside, analysts plainly believe Bio-Techne is more favorable than Mettler-Toledo International.
Summary
Bio-Techne beats Mettler-Toledo International on 8 of the 15 factors compared between the two stocks.
Get Bio-Techne News Delivered to You Automatically
Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TECH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bio-Techne Competitors List
Related Companies and Tools
This page (NASDAQ:TECH) was last updated on 7/3/2025 by MarketBeat.com Staff
